Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Neurofibromatosis Type I and Plexiform Neurofibromas.
Document Type
Journal Article
Publication Date
3-1-2013
Journal
Pediatric blood & cancer
Volume
60
Issue
3
Inclusive Pages
396–401
DOI
10.1002/pbc.24281
Keywords
Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Male; Maximum Tolerated Dose; Neurofibroma, Plexiform; Neurofibromatosis 1; Niacinamide; Phenylurea Compounds; Sorafenib
APA Citation
Kim, A., Dombi, E., Tepas, K., Fox, E., Martin, S., Wolters, P., Balis, F., Jayaprakash, N., Turkbey, B., Muradyan, N., Choyke, P., Reddy, A., Korf, B., & Widemann, B. (2013). Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Neurofibromatosis Type I and Plexiform Neurofibromas.. Pediatric blood & cancer, 60 (3). http://dx.doi.org/10.1002/pbc.24281
Peer Reviewed
1